Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Ascending Dose Escalation Clinical Trial to Investigate Safety and Pharmacokinetics of VVZ-149 Injection in Healthy Older Male Volunteers

NCT02333318 is registered in ClinicalTrials.gov with Vivozon, Inc. as lead sponsor.

NCT NCT02333318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02333318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Ascending Dose Escalation Clinical Trial to Investigate Safety and Pharmacokinetics of VVZ-149 Injection in Healthy Older Male Volunteers
Lead sponsor
Vivozon, Inc.
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2014
Completion date
October 31, 2014
Enrollment
24 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy